What does DR. VERBRUGGEN - DR. DE VIS do?

DR. VERBRUGGEN - DR. DE VIS is a specialist medical practice in Meise. Private Limited, started on 20 November 2002, 1 establishment.

What is the address of DR. VERBRUGGEN - DR. DE VIS?

The registered office of DR. VERBRUGGEN - DR. DE VIS is located at Plasstraat 54, 1860 Meise.

Is DR. VERBRUGGEN - DR. DE VIS still active?

Yes. According to the CBE (17 September 2026) DR. VERBRUGGEN - DR. DE VIS is active, legal situation “Normale toestand”, started on 20 November 2002.

Is DR. VERBRUGGEN - DR. DE VIS registered on Peppol?

Yes, DR. VERBRUGGEN - DR. DE VIS is registered on the Peppol network with ID 0208:0478799225.

What is the enterprise number of DR. VERBRUGGEN - DR. DE VIS?

The enterprise number of DR. VERBRUGGEN - DR. DE VIS is BE0478799225.

When was DR. VERBRUGGEN - DR. DE VIS founded?

DR. VERBRUGGEN - DR. DE VIS was founded on 20 November 2002.

Who are the directors of DR. VERBRUGGEN - DR. DE VIS?

According to the 2025 annual accounts, the directors of DR. VERBRUGGEN - DR. DE VIS are: Margareta De Vis, Jan Verbruggen.

Is DR. VERBRUGGEN - DR. DE VIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 November 2002; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. VERBRUGGEN - DR. DE VIS make in 2025?

DR. VERBRUGGEN - DR. DE VIS posted a profit after taxes of € 206,592 in financial year 2025.

What is the revenue of DR. VERBRUGGEN - DR. DE VIS?

As a small company, DR. VERBRUGGEN - DR. DE VIS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 259,978.

DR. VERBRUGGEN - DR. DE VIS (Private Limited) - Meise

Dossier DR. VERBRUGGEN - DR. DE VIS, printed on 17 September 2026 from databakkes.be/en/0478799225/dr-verbruggen-dr-de-vis. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VERBRUGGEN - DR. DE VIS from Meise, company number BE0478799225, closed financial year 2025 with a result of € 206,592 after tax. For that financial year DR. VERBRUGGEN - DR. DE VIS recorded a gross margin of € 259,978 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 173,476 to € 206,592. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Growing

€ 1.3 million

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 206,592

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71,234

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.3 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,326

▲ 177% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,419

▼ 35% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 291,048 Gross margin 2022: € 291,048 First fiscal year in the series	€ 259,233 Gross margin 2023: € 259,233 ▼ 11% vs 2022 (€ 291,048) Unfavourable step	€ 258,888 Gross margin 2024: € 258,888 Unchanged (€ 259,233) Unfavourable step	€ 259,978 Gross margin 2025: € 259,978 Unchanged (€ 258,888) Favourable step
Profit after taxes	€ 194,544 Profit after taxes 2022: € 194,544 First fiscal year in the series	€ 169,832 Profit after taxes 2023: € 169,832 ▼ 13% vs 2022 (€ 194,544) Unfavourable step	€ 173,476 Profit after taxes 2024: € 173,476 ▲ 2% vs 2023 (€ 169,832) Favourable step	€ 206,592 Profit after taxes 2025: € 206,592 ▲ 19% vs 2024 (€ 173,476) Favourable step	▲ 19%
Equity	€ 1,001,180 Equity 2022: € 1,001,180 First fiscal year in the series	€ 1,068,569 Equity 2023: € 1,068,569 ▲ 7% vs 2022 (€ 1,001,180) Favourable step	€ 1,134,340 Equity 2024: € 1,134,340 ▲ 6% vs 2023 (€ 1,068,569) Favourable step	€ 1,340,932 Equity 2025: € 1,340,932 ▲ 18% vs 2024 (€ 1,134,340) Favourable step	▲ 18%
Total debts	€ 269,267 Total debts 2022: € 269,267 First fiscal year in the series	€ 262,060 Total debts 2023: € 262,060 ▼ 3% vs 2022 (€ 269,267) Favourable step	€ 63,442 Total debts 2024: € 63,442 ▼ 76% vs 2023 (€ 262,060) Favourable step	€ 94,350 Total debts 2025: € 94,350 ▲ 49% vs 2024 (€ 63,442) Unfavourable step	▲ 49%
Cash	€ 256,933 Cash 2022: € 256,933 First fiscal year in the series	€ 51,676 Cash 2023: € 51,676 ▼ 80% vs 2022 (€ 256,933) Unfavourable step	€ 103,075 Cash 2024: € 103,075 ▲ 99% vs 2023 (€ 51,676) Favourable step	€ 71,234 Cash 2025: € 71,234 ▼ 31% vs 2024 (€ 103,075) Unfavourable step	▼ 31%
Land & buildings	€ 1,540 Land & buildings 2022: € 1,540 First fiscal year in the series	€ 5,005 Land & buildings 2023: € 5,005 ▲ 225% vs 2022 (€ 1,540) Unchanged	€ 3,697 Land & buildings 2024: € 3,697 ▼ 26% vs 2023 (€ 5,005) Unchanged	€ 2,390 Land & buildings 2025: € 2,390 ▼ 35% vs 2024 (€ 3,697) Unchanged	▼ 35%
Retained profit	€ 982,580 Retained profit 2022: € 982,580 First fiscal year in the series	€ 1,049,969 Retained profit 2023: € 1,049,969 ▲ 7% vs 2022 (€ 982,580) Favourable step	€ 1,115,740 Retained profit 2024: € 1,115,740 ▲ 6% vs 2023 (€ 1,049,969) Favourable step	€ 1,322,332 Retained profit 2025: € 1,322,332 ▲ 19% vs 2024 (€ 1,115,740) Favourable step	▲ 19%
Dividend	€ 113,323 Dividend 2022: € 113,323 First fiscal year in the series	€ 102,443 Dividend 2023: € 102,443 ▼ 10% vs 2022 (€ 113,323) Unchanged	€ 107,705 Dividend 2024: € 107,705 ▲ 5% vs 2023 (€ 102,443) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 107,705) Unchanged	▼ 100%
Balance sheet total	€ 1,270,446 Balance sheet total 2022: € 1,270,446 First fiscal year in the series	€ 1,330,629 Balance sheet total 2023: € 1,330,629 ▲ 5% vs 2022 (€ 1,270,446) Unchanged	€ 1,197,782 Balance sheet total 2024: € 1,197,782 ▼ 10% vs 2023 (€ 1,330,629) Unchanged	€ 1,435,282 Balance sheet total 2025: € 1,435,282 ▲ 20% vs 2024 (€ 1,197,782) Unchanged	▲ 20%

Key figures of DR. VERBRUGGEN - DR. DE VIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VERBRUGGEN - DR. DE VIS?

What happened at DR. VERBRUGGEN - DR. DE VIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 11, 2026 New annual accounts for financial year 2025: profit of € 206,592 (▲ 19% vs 2024). Source: NBB ↗
2018 Margareta De Vis became a director. NBB
2018 Jan Verbruggen became a director. NBB
Jul 1, 2005 New establishment in Meise. KBO
Nov 20, 2002 Start of the company according to the CBE. KBO

In short

From € 194,544 profit in 2022 to € 206,592 profit in 2025.

Paid € 346,392 in corporate taxes since 2022.

Best year ever: 2025, with € 206,592 profit.

Paid out € 323,471 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VERBRUGGEN - DR. DE VIS? We notify you, reason included.

Follow DR. VERBRUGGEN - DR. DE VIS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Margareta De Vis Jan Verbruggen

IMMO DE BRON

DR. VERBRUGGEN - DR. DE VIS

Behind DR. VERBRUGGEN - DR. DE VIS are Margareta De Vis and Jan Verbruggen. Margareta De Vis is also behind IMMO DE BRON.

See the full network in the app

Directors

According to the 2025 annual accounts

Margareta De Vis

Director

Also active at: IMMO DE BRON

since 2018

Jan Verbruggen

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Plasstraat 54

1860 Meise

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0478.799.225
VAT number: BE 0478.799.225
Registered office: Plasstraat 54, 1860 Meise
Names & denominations: DR. VERBRUGGEN - DR. DE VIS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 November 2002
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗